• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普拉德-威利综合征转化动物模型的临床前测试:概述与差距分析

Preclinical Testing in Translational Animal Models of Prader-Willi Syndrome: Overview and Gap Analysis.

作者信息

Carias K Vanessa, Wevrick Rachel

机构信息

Department of Medical Genetics, University of Alberta, Edmonton, AB, Canada.

出版信息

Mol Ther Methods Clin Dev. 2019 Mar 14;13:344-358. doi: 10.1016/j.omtm.2019.03.001. eCollection 2019 Jun 14.

DOI:10.1016/j.omtm.2019.03.001
PMID:30989085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6447752/
Abstract

Prader-Willi syndrome (PWS) is a rare neurodevelopmental disorder causing endocrine, musculoskeletal, and neurological dysfunction. PWS is caused by the inactivation of contiguous genes, complicating the development of targeted therapeutics. Clinical trials are now underway in PWS, with more trials to be implemented in the next few years. PWS-like endophenotypes are recapitulated in gene-targeted mice in which the function of one or more PWS genes is disrupted. These animal models can guide priorities for clinical trials or provide information about efficacy of a compound within the context of the specific disease. We now review the current status of preclinical studies that measure the effect of therapeutics on PWS-like endophenotypes. Seven categories of therapeutics (oxytocin and related compounds, K-ATP channel agonists, melanocortin 4 receptor agonists, incretin mimetics and/or GLP-1 receptor agonists, cannabinoids, ghrelin agents, and [cactus] extract) have been tested for their effect on endophenotypes in both PWS animal models and clinical trials. Many other therapeutics have been tested in clinical trials, but not preclinical models of PWS or vice versa. Fostering dialogs among investigators performing preclinical validation of animal models and those implementing clinical studies will accelerate the discovery and translation of therapies into clinical practice in PWS.

摘要

普拉德-威利综合征(PWS)是一种罕见的神经发育障碍,可导致内分泌、肌肉骨骼和神经功能障碍。PWS是由相邻基因的失活引起的,这使得靶向治疗的开发变得复杂。目前正在进行针对PWS的临床试验,未来几年还将开展更多试验。在基因靶向小鼠中重现了类似PWS的内表型,其中一个或多个PWS基因的功能被破坏。这些动物模型可以指导临床试验的重点,或在特定疾病背景下提供有关化合物疗效的信息。我们现在回顾临床前研究的现状,这些研究测量了治疗方法对类似PWS内表型的影响。七类治疗方法(催产素及相关化合物、钾离子通道激动剂、黑皮质素4受体激动剂、肠促胰岛素类似物和/或胰高血糖素样肽-1受体激动剂、大麻素、胃饥饿素制剂和[仙人掌]提取物)已在PWS动物模型和临床试验中测试了它们对内表型的影响。许多其他治疗方法已在临床试验中进行了测试,但未在PWS临床前模型中进行测试,反之亦然。促进在对动物模型进行临床前验证的研究人员与开展临床研究的人员之间的对话,将加速PWS治疗方法的发现并将其转化为临床实践。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2748/6447752/9acf3e2ac877/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2748/6447752/9acf3e2ac877/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2748/6447752/9acf3e2ac877/gr1.jpg

相似文献

1
Preclinical Testing in Translational Animal Models of Prader-Willi Syndrome: Overview and Gap Analysis.普拉德-威利综合征转化动物模型的临床前测试:概述与差距分析
Mol Ther Methods Clin Dev. 2019 Mar 14;13:344-358. doi: 10.1016/j.omtm.2019.03.001. eCollection 2019 Jun 14.
2
Disentangling ingestive behavior-related phenotypes in Prader-Willi syndrome: Integrating information from nonclinical studies and clinical trials to better understand the pathophysiology of hyperphagia and obesity.解析普拉德-威利综合征中与摄食行为相关的表型:整合来自非临床研究和临床试验的信息,以更好地理解食欲亢进和肥胖的病理生理学。
Physiol Behav. 2020 May 15;219:112864. doi: 10.1016/j.physbeh.2020.112864. Epub 2020 Mar 7.
3
Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome.普拉德-威利综合征及普拉德-威利样综合征的遗传学
Ann Pediatr Endocrinol Metab. 2016 Sep;21(3):126-135. doi: 10.6065/apem.2016.21.3.126. Epub 2016 Sep 30.
4
Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.成人普拉德-威利综合征的内分泌和代谢方面,特别强调生长激素治疗的效果。
Growth Horm IGF Res. 2004 Feb;14(1):1-15. doi: 10.1016/j.ghir.2003.09.003.
5
Caralluma Fimbriata Supplementation Improves the Appetite Behavior of Children and Adolescents with Prader-Willi Syndrome.食用肉珊瑚补充剂可改善普拉德-威利综合征患儿及青少年的食欲行为。
N Am J Med Sci. 2015 Nov;7(11):509-16. doi: 10.4103/1947-2714.170611.
6
Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.普拉德-威利综合征:临床、遗传及内分泌学研究结果综述
J Endocrinol Invest. 2015 Dec;38(12):1249-63. doi: 10.1007/s40618-015-0312-9. Epub 2015 Jun 11.
7
Genotype-Phenotype Relationships and Endocrine Findings in Prader-Willi Syndrome.普拉德-威利综合征的基因型-表型关系及内分泌学发现
Front Endocrinol (Lausanne). 2019 Dec 13;10:864. doi: 10.3389/fendo.2019.00864. eCollection 2019.
8
Chronic diazoxide treatment decreases fat mass and improves endurance capacity in an obese mouse model of Prader-Willi syndrome.慢性地佐辛治疗可减少肥胖 Prader-Willi 综合征小鼠模型的脂肪量并提高其耐力。
Mol Genet Metab. 2018 Apr;123(4):511-517. doi: 10.1016/j.ymgme.2018.02.018. Epub 2018 Feb 27.
9
The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.普拉德-威利综合征临床诊断标准的目的变化及修订标准建议
Pediatrics. 2001 Nov;108(5):E92. doi: 10.1542/peds.108.5.e92.
10
High unacylated ghrelin levels support the concept of anorexia in infants with prader-willi syndrome.高未酰化胃饥饿素水平支持普拉德-威利综合征婴儿厌食症的概念。
Orphanet J Rare Dis. 2016 May 4;11(1):56. doi: 10.1186/s13023-016-0440-0.

引用本文的文献

1
Environmental Enrichment Normalizes Metabolic Function in the Murine Model of Prader-Willi Syndrome Magel2-Null Mice.环境富集使普拉德-威利综合征马盖2基因敲除小鼠模型的代谢功能正常化。
Endocrinology. 2025 Feb 5;166(3). doi: 10.1210/endocr/bqaf001.
2
A genetic condition that spans both extremes of the nutritional spectrum.一种跨越营养谱两端极端情况的遗传病症。
Pract Lab Med. 2024 May 23;40:e00405. doi: 10.1016/j.plabm.2024.e00405. eCollection 2024 May.
3
Transplantation of gut microbiota derived from patients with schizophrenia induces schizophrenia-like behaviors and dysregulated brain transcript response in mice.

本文引用的文献

1
A multidisciplinary approach to the clinical management of Prader-Willi syndrome.一种针对普拉德-威利综合征临床管理的多学科方法。
Mol Genet Genomic Med. 2019 Mar;7(3):e514. doi: 10.1002/mgg3.514. Epub 2019 Jan 29.
2
Ghrelin Receptor Agonist Rescues Excess Neonatal Mortality in a Prader-Willi Syndrome Mouse Model.生长激素释放肽受体激动剂可挽救 Prader-Willi 综合征小鼠模型中的过度新生儿死亡率。
Endocrinology. 2018 Dec 1;159(12):4006-4022. doi: 10.1210/en.2018-00801.
3
Caralluma fimbriata extract activity involves the 5-HT2c receptor in PWS Snord116 deletion mouse model.
移植来自精神分裂症患者的肠道微生物群会在小鼠中诱发类似精神分裂症的行为和大脑转录反应失调。
Schizophrenia (Heidelb). 2024 Apr 8;10(1):44. doi: 10.1038/s41537-024-00460-6.
4
Hormonal Imbalances in Prader-Willi and Schaaf-Yang Syndromes Imply the Evolution of Specific Regulation of Hypothalamic Neuroendocrine Function in Mammals.普拉德-威利和 Schaaf-Yang 综合征中的激素失衡暗示了哺乳动物下丘脑神经内分泌功能特定调节的进化。
Int J Mol Sci. 2023 Aug 23;24(17):13109. doi: 10.3390/ijms241713109.
5
Hypothalamic AAV-BDNF gene therapy improves metabolic function and behavior in the -null mouse model of Prader-Willi syndrome.下丘脑腺相关病毒-脑源性神经营养因子基因疗法改善普拉德-威利综合征β-珠蛋白基因缺失小鼠模型的代谢功能和行为。
Mol Ther Methods Clin Dev. 2022 Sep 27;27:131-148. doi: 10.1016/j.omtm.2022.09.012. eCollection 2022 Dec 8.
6
Oxytocin-based therapies for treatment of Prader-Willi and Schaaf-Yang syndromes: evidence, disappointments, and future research strategies.基于催产素的治疗方法用于治疗普拉德-威利和 Schaaf-Yang 综合征:证据、失望和未来研究策略。
Transl Psychiatry. 2022 Aug 8;12(1):318. doi: 10.1038/s41398-022-02054-1.
7
The Metabolic Efficacy of a Cannabidiolic Acid (CBDA) Derivative in Treating Diet- and Genetic-Induced Obesity.大麻素二酸(CBDA)衍生物治疗饮食和遗传诱导肥胖的代谢功效。
Int J Mol Sci. 2022 May 17;23(10):5610. doi: 10.3390/ijms23105610.
8
Anti-Obesity Medication Use in Children and Adolescents with Prader-Willi Syndrome: Case Review and Literature Search.普拉德-威利综合征儿童及青少年使用抗肥胖药物:病例回顾与文献检索
J Clin Med. 2021 Sep 30;10(19):4540. doi: 10.3390/jcm10194540.
9
Generation of hypothalamic arcuate organoids from human induced pluripotent stem cells.从人诱导多能干细胞生成下丘脑弓状器官。
Cell Stem Cell. 2021 Sep 2;28(9):1657-1670.e10. doi: 10.1016/j.stem.2021.04.006. Epub 2021 May 6.
10
Converging vulnerability factors for compulsive food and drug use.强迫性食物和药物使用的趋同脆弱性因素。
Neuropharmacology. 2021 Sep 15;196:108556. doi: 10.1016/j.neuropharm.2021.108556. Epub 2021 Apr 20.
南非叶提取物的活性涉及到 PWS Snord116 缺失小鼠模型中的 5-HT2c 受体。
Brain Behav. 2018 Dec;8(12):e01102. doi: 10.1002/brb3.1102. Epub 2018 Oct 23.
4
Magel2 Modulates Bone Remodeling and Mass in Prader-Willi Syndrome by Affecting Oleoyl Serine Levels and Activity.Magel2 通过影响油酰丝氨酸水平和活性调节 Prader-Willi 综合征中的骨重塑和骨量。
J Bone Miner Res. 2019 Jan;34(1):93-105. doi: 10.1002/jbmr.3591. Epub 2018 Oct 22.
5
Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome.鼻腔给予卡贝缩宫素可减少普拉德-威利综合征患者的多食症。
JCI Insight. 2018 Jun 21;3(12). doi: 10.1172/jci.insight.98333.
6
Impaired melanocortin pathway function in Prader-Willi syndrome gene-Magel2 deficient mice.Prader-Willi 综合征基因 Magel2 缺陷小鼠中黑素皮质素途径功能受损。
Hum Mol Genet. 2018 Sep 15;27(18):3129-3136. doi: 10.1093/hmg/ddy216.
7
Cognitive deficits in the Snord116 deletion mouse model for Prader-Willi syndrome.Snord116 缺失小鼠模型用于研究普拉德-威利综合征的认知缺陷。
Neurobiol Learn Mem. 2019 Nov;165:106874. doi: 10.1016/j.nlm.2018.05.011. Epub 2018 May 23.
8
Snord116-dependent diurnal rhythm of DNA methylation in mouse cortex.小鼠大脑皮层中依赖于 Snord116 的 DNA 甲基化昼夜节律。
Nat Commun. 2018 Apr 24;9(1):1616. doi: 10.1038/s41467-018-03676-0.
9
Chitayat-Hall and Schaaf-Yang syndromes:a common aetiology: expanding the phenotype of -related disorders.奇塔亚特-霍尔综合征和邵-杨综合征:一种共同的发病机制:扩展相关疾病的表型。
J Med Genet. 2018 May;55(5):316-321. doi: 10.1136/jmedgenet-2017-105222. Epub 2018 Mar 29.
10
Whole-exome Sequencing Helps the Diagnosis and Treatment in Children with Neurodevelopmental Delay Accompanied Unexplained Dyspnea.全外显子组测序有助于诊断和治疗伴有不明原因呼吸困难的神经发育迟缓患儿。
Sci Rep. 2018 Mar 26;8(1):5214. doi: 10.1038/s41598-018-23503-2.